Water-Based Allergen Denaturing Composition for Safer Airborne Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preventing allergic reactions to respiratory allergens, such as mite, pollen, pet, mold, and fungal allergens, are limited in effectiveness, require significant effort and time, and can cause side effects, while alcohol-based disinfectants pose safety risks.

Innovation Solution

A water-based composition using tannic acid, anionic surfactants, and herbal essential oils, or cyclodextrin with acids and essential oils, denatures allergens by breaking peptide bonds and hydrogen bonds, preventing allergens from binding to immunoglobulin E receptors and reducing histamine release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If alcohol-based disinfectants are used to destroy allergens, then allergen destruction effectiveness is improved, but safety risks increase due to flammability

Engineering Contradiction:
Improveallergen destruction effectivenessVSAvoidsafety risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical composition parameters by replacing alcohol-based disinfectants with water-based compositions containing tannic acid, anionic surfactants, and herbal essential oils. This parameter change maintains allergen destruction effectiveness while eliminating flammability safety risks associated with alcohol-based solutions.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite material system combining multiple active ingredients (tannic acid, anionic surfactants, herbal essential oils) in a water-based formulation. This composite approach achieves effective allergen denaturation through synergistic interactions while maintaining safety by eliminating flammable components.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If brooming and dusting processes are used to remove allergens, then allergen exposure is reduced, but time and effort requirements increase

Engineering Contradiction:
Improveallergen exposureVSAvoidtime and effort
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-treating surfaces and environments with the water-based composition before allergens can accumulate or be inhaled. This preventive application eliminates the need for subsequent manual cleaning efforts while maintaining reduced allergen exposure.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces mechanical cleaning systems (brooming, dusting) with a chemical denaturation system. The composition chemically denatures allergens upon contact, substituting manual mechanical removal processes with an automated chemical action that requires no human effort or time investment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Object-affected harmful factors

If drugs such as antihistamines and corticosteroids are used to treat allergic symptoms, then symptom relief is improved, but side effects increase

Engineering Contradiction:
Improveallergic symptomsVSAvoidside effects
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by denaturing allergens in the environment before they can trigger immune responses and symptomatic reactions. This upstream intervention prevents the need for downstream pharmacological symptom management, eliminating drug-related side effects while maintaining symptom relief.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts the harmful allergens into harmless denatured proteins through chemical modification. By transforming the allergenic substances themselves rather than treating symptoms, the system eliminates the need for pharmaceutical interventions and their associated side effects while maintaining therapeutic benefit.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

4Reliability

If immunotherapy tablets are used to desensitize the body to allergens, then long-term protection is improved, but treatment complexity and time requirements increase

Engineering Contradiction:
Improvelong-term protectionVSAvoidtreatment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action at the environmental level by denaturing allergens before exposure, rather than requiring long-term immunological reconditioning of the patient. This approach achieves protection through immediate environmental modification rather than complex, prolonged therapeutic protocols.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively denatures a wide range of allergens, reducing exposure and allergic symptoms without side effects, and can be applied to various surfaces, eliminating the need for time-consuming cleaning and drug use.

Implementation Method 1

denatures allergens by breaking peptide bonds and hydrogen bonds

Methodology Applied
Scientific EffectPeptide bond breaking: Hydrolysis

Implementation Method 2

denatures allergens by breaking peptide bonds and hydrogen bonds

Methodology Applied
Scientific EffectHydrogen bond breaking:

Implementation Method 3

versions of compositions containing an anionic surfactant or cyclodextrin

Methodology Applied
Scientific EffectInclusion complex formation:

Implementation Method 4

preventing allergens from binding to immunoglobulin E receptors and reducing histamine release

Methodology Applied
Scientific EffectAntibody-antigen binding prevention:

Data Source

PatentUS20260007792A1Compositions for denaturation of respiratory allergens
Publication Date: 2026.01.08 IFL PHARMA ILAC SANAYI & TICARET ANONIM SIRKETI
  • US20260007792A1 patent drawing
  • US20260007792A1 patent drawing

AI summary

Disclosed are compositions developed for the denaturation of respiratory allergens, such as mite, pollen, feline, canine, mold and fungal allergens. In particular, disclosed are water based compositions of vegetable origin, which prevent allergic reactions in the body by denaturing respiratory allergens before they enter the body through the respiratory tract, while they are still in the environment. Different versions of compositions are disclosed containing at least one acid, at least one herbal essential oil, an anionic surfactant or cyclodextrin, as well as water.